Gardasil 9

Land: Norge

Språk: norska

Källa: Statens legemiddelverk

Aktiva substanser:

Humant papillomavirus, type 6 L1 protein, rekombinant / Humant papillomavirus, type 11 L1 protein, rekombinant / Humant papillomavirus, type 16 L1 protein, rekombinant / Humant papillomavirus, type 18 L1 protein, rekombinant / Humant papillomavirus, type 31 L1 protein, rekombinant / Humant papillomavirus, type 33 L1 protein, rekombinant / Humant papillomavirus, type 45 L1 protein, rekombinant / Humant papillomavirus, type 52 L1 protein, rekombinant / Humant papillomavirus, type 58 L1 protein, rekombinant

Tillgänglig från:

Orifarm AS

ATC-kod:

J07BM03

INN (International namn):

Humant papillomavirus, type 6 L1 protein, rekombinant / Humant papillomavirus, type 11 L1 protein, rekombinant / Humant papillomavirus, type 16 L1 protein, rekombinant / Humant papillomavirus, type 18 L1 protein, rekombinant / Humant papillomavirus, type 31 L1 protein, rekombinant / Humant papillomavirus, type 33 L1 protein, rekombinant / Humant papillomavirus, type 45 L1 protein, rekombinant / Humant papillomavirus, type 52 L1 protein, rekombinant / Humant papillomavirus, type 58 L1 protein, rekombinant

Läkemedelsform:

Injeksjonsvæske, suspensjon

Enheter i paketet:

Ferdigfylt sprøyte 1x0.5 ml

Receptbelagda typ:

C

Bemyndigande status:

Markedsført

Tillstånd datum:

2022-04-01